ArticleScientific reports2026
A model of multi-view contrastive hypergraph learning for predicting circRNA-disease associations.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- CSDPCDA: A miRNA-Mediated Cross-Semantic Regulatory Network Framework for Predicting circRNA-Disease Associations.International journal of molecular sciences · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
In recent years, circRNAs have been found to be closely related to a variety of human diseases. In-depth exploration of their potential associations with diseases is of great value for understanding disease mechanisms and auxiliary diagnosis. To address the association between circRNAs and human diseases, this paper proposes a multi-view contrastive learning model MCHG that integrates attention mechanism and hypergraph structure modeling. The model first constructs a multi-view hypergraph structure based on the circRNA-disease heterogeneous network to capture high-order relationships between nodes. Subsequently, a hypergraph convolutional network is used to extract structured features from different perspectives, and an improved contrastive learning strategy is used to enhance the discriminative ability of feature representation. Furthermore, the model improves the convolutional block attention model, weighting features from two dimensions: channel and space, highlighting key information and suppressing redundant interference. The fused multi-view representations are input into the neural network projection module to achieve efficient prediction of potential associations by reconstructing the circRNA-disease association matrix. Validation experiments on the CircR2Disease dataset show that MCHG achieves an AUC of 0.9394 and an AUPR of 0.9602. Compared with previous models, MCHG can simultaneously model the high-order structural relationships and multi-perspective complementary information in the circRNA-disease heterogeneous network. Furthermore, it improves the quality of feature representation through improved contrastive learning and a two-dimensional attention weighting mechanism, thereby enhancing the accuracy and robustness of potential association prediction. In addition, among the top 25 unknown CDAs predicted by MCHG, 23 were confirmed by relevant literature, indicating that MCHG can effectively predict potential CDAs and provide assistance for further biological wet experiments.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.